NSCLC, STAGE III
Clinical trials for NSCLC, STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE III trials appear
Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail lung cancer patients: Chemo-Free combo shows promise
Disease control CompletedThis phase II trial tested a combination of thoracic radiotherapy and the immunotherapy drug durvalumab in 51 elderly or frail patients with stage III lung cancer who could not receive chemotherapy. The goal was to see if this approach is safe and can shrink tumors. The study foc…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New cocktail of drugs and radiation takes on tough lung cancer
Disease control CompletedThis phase 2 trial tested whether adding two newer drugs—GFH018 and toripalimab—to standard chemoradiotherapy could help people with stage III non-small cell lung cancer that cannot be surgically removed. The study enrolled 65 adults and measured how many patients saw their tumor…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC